These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5676614)

  • 1. [Methyclothiazide in the therapy of patients with heart insufficiency].
    Flensted-Jensen E
    Ugeskr Laeger; 1968 Feb; 130(7):278-81. PubMed ID: 5676614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thiazide therapy of hypertension and its effect on hyperuricemia].
    Namba H; Takayama J; Miyazaki H; Tsuboniwa M
    Nihon Rinsho; 1969 May; 27(5):1483-8. PubMed ID: 5817509
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of a diuretic (methyclothiazide) in cirrhosis, obesity, cardiac diseases. Apropos of 45 observations].
    Roux M
    Clinique (Paris); 1965 May; 60(607):371-5. PubMed ID: 5833445
    [No Abstract]   [Full Text] [Related]  

  • 4. Parglyline hydrochloride and methyclothiazide combined in the treatment of hypertension in diabetic patients.
    Pickering BI
    Ariz Med; 1968 Nov; 25(11):974-9. PubMed ID: 5723900
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of hypertension using methyclothiazide pargyline].
    Rojas Duarte M
    Prensa Med Argent; 1968 Sep; 55(31):1515-8. PubMed ID: 5720927
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive effect of pargyline and methyclothiazide in combination.
    Sutnick AI; Frankl WS; Fewell JW; Esbenshade JH; Bello CT
    Vasc Dis; 1966 Jun; 3(3):145-55. PubMed ID: 5939435
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and biological effects of methyclothiazide (Enduron). (Apropos of 30 cases)].
    de Grailly R; Leuret JP
    J Med Bord; 1966 Aug; 143(8):1147-55. PubMed ID: 5954815
    [No Abstract]   [Full Text] [Related]  

  • 8. Pargyline hydrochloride combined with methyclothiazide in the treatment of essential hypertension.
    Hamm HJ
    Curr Ther Res Clin Exp; 1966 Aug; 8(8):378-83. PubMed ID: 4958153
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of arterial hypertension with a pargyline and methyclothiazide compound].
    Cruz J; Bezas AG; Cruz HM; de Almeida SS
    Rev Bras Med; 1967 May; 24(5):353-8. PubMed ID: 5603878
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypotensive action of the pargyline-methyclothiazide combination].
    Saldanha RV; Adachi T; Silve PP; Giannini SD; Thome O; Diament J
    Rev Bras Med; 1968 Feb; 25(2):102-7. PubMed ID: 5656163
    [No Abstract]   [Full Text] [Related]  

  • 11. Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.
    Tamirisa KP; Aaronson KD; Koelling TM
    Am Heart J; 2004 Dec; 148(6):971-8. PubMed ID: 15632880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of sulfamide diuretic: methyclothiazide].
    Hertault J
    Sem Ther; 1964 Nov; 40(9):573-5. PubMed ID: 5878674
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of uncomplicated arterial hypertension with methyclothiazide].
    Spach MO; Bloch R; Imbs JL; Schwartz J
    Therapie; 1978; 33(3):313-20. PubMed ID: 356338
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of the hypotensive effect of pargyline hydrochloride and methyclothiazide].
    Borrero J; Martínez G; Cárdenas C; Restrepo D; Escobar A
    Antioquia Med; 1965; 15(3):159-73. PubMed ID: 5318105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of daily treatment with hypothiazide and novurit on the acid-base balance and mineral metabolism in patients with circulatory insufficiency].
    Kabakov AI
    Ter Arkh; 1969 Jun; 41(6):74-9. PubMed ID: 5364563
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
    Bergler-Klein J; Sochor H; Pouleur H; Pacher R; Porenta G; Glogar D
    J Cardiovasc Pharmacol; 1994 Aug; 24(2):194-8. PubMed ID: 7526050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypotensive effect of a pargyline methylchlorothiazide combination. Its mechanism of action].
    Melfi M; Colodro I
    Rev Med Chil; 1968 Jan; 96(1):22-6. PubMed ID: 5732739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hypercaliciuria in calcium diabetes and in idiopathic osteoporosis in young subjects with a new chlorothiazide: methyclothiazide].
    Bordier P; de Sèze S; Hioco D
    Sem Ther; 1968 Apr; 44(4):238-41. PubMed ID: 5759696
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials of an antihypertensive drug, a combination of methylclothiazide and deserpidine].
    Hatt PY
    Clinique (Paris); 1965 Nov; 60(613):749-54. PubMed ID: 5859341
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erythrocyte electrolyte concentrations as an indicator of digitalis therapy].
    Okumura K; Ogawa K; Mizutani K; Kato T; Imai Y; Ito S; Kawamura M
    Kokyu To Junkan; 1982 Aug; 30(8):819-24. PubMed ID: 7134689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.